latest news releases from the newsroom
Careside Reports Third Quarter 2002 Results
CULVER CITY, Calif., Nov. 19, 2002 (PRIMEZONE) -- Careside, Inc. (AMEX:CSA), a provider of point-of-care blood analysis instrumentation and records management, today announced its results for the third quarter ended September 30, 2002. Revenues for the third quarter were $78,000, compared to $305,000 in the prior year period. While revenues decreased, operating expenses in the third quarter of 2002 declined 45% percent to $1.4 million, from $2.5 million in the third quarter of 2001. However, for the three months ended September 30, 2002, the Company incurred a net loss of $2.3 million, which resulted in a $0.12 net loss per share. This compares with the net loss for the same period in the prior year of $3.3 million, which resulted in a net loss per share of $0.29.
Biacore Cell-Based Assay System Introduced
UPPSALA, Sweden, Nov. 19, 2002 (PRIMEZONE) -- Biacore International AB (Biacore) (SSE:BCOR) (Nasdaq:BCOR) today announced the introduction of its new cell-based assay system at the first of a series of industry meetings involving drug discovery experts from many of the top 20 pharmaceutical companies. The seminar program will culminate in a poster presentation at IBC's Cell-Based Assays & Screening Conference in Philadelphia, PA, December 4-6, 2002. The new system, Procel(TM), is designed specifically for cell-based secondary screening and pharmacology profiling of potential new drug leads and will complement Biacore's existing molecular-based systems for drug discovery.
Keyware Technologies N.V. Announces Q3 Results
ANDERLECHT, Belgium, Nov. 19, 2002 (PRIMEZONE) -- Keyware Technologies N.V. ("Keyware") (NASDAQ Europe:KEYW), one of the world's leading providers of multi-application smart card solutions, today announced the financial results for the quarter ended September 30, 2002.